Cellevate Story
From R&D to industrial supplier
1988
NanoLund – a part of Lund University (Sweden) is founded and has led to the creation of >10 nanotechnology spin off companies. Prominent public examples include Acconeer, Obducat, Acousort and Spermosens
2014
Cellevate founded 2014 as a spinout from NanoLund. Development of Generation 1 Cellevat3d™ = Conventional technology reinvented, in close collaborations with researchers
2016
Generation 2 Cellevat3d™ was developed to enable a larger product portfolio and improved performance in cell-co-culture applications
2017
Generation 1 and 2 Cellevat3d™ R&D Customized Solutions Sales in neurology, immunology and cancer
2020
Generation 3 Cellevat3d™ was developed
2021
Patent for production method submitted
2021 – 2024
Validation studies Cellevat3d™ in cell culture industrial applications. Pipeline development in downstream applications
2023
Launch and commercialization of cytokine analysis plates
2024
Launch and commercialization of Cellevat3d™ microcarriers
